600671 Hangzhou Tianmushan Pharmaceutical Enterprise
- 8.28
- -0.10-1.19%
Hangzhou Tianmushan Pharmaceutical Enterprise News
Notice of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on convening the 2nd Extraordinary General Meeting of Shareholders in 2024
Announcement of Resolutions of the 23rd Meeting of the 11th Board of Supervisors of Hangzhou Tianmushan Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 30th Meeting of the 11th Board of Directors of Hangzhou Tianmushan Pharmaceutical Co., Ltd.
Announcement of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on the implementation of production capacity improvement and technological transformation projects by its wholly-owned subsidiary Huangshan Tianmu Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Hangzhou Tianmushan Pharmaceutical Co., Ltd.
Legal Opinion of Shanghai Zechang Law Firm on the 2023 Annual General Meeting of Shareholders of Hangzhou Tianmusan Pharmaceutical Co., Ltd.
Announcement of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on receiving the Shanghai Stock Exchange's “Inquiry Letter on the Company's 2023 Annual Report Information Disclosure”
Announcement of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on holding the 2023 annual results briefing
Hangzhou Tianmusan Pharmaceutical Co., Ltd. 2023 Annual General Meeting of Shareholders Meeting Materials
2023 Independent Director Debriefing Report (Gai Yongmei)
2023 Independent Director Debriefing Report (Zhao Xiang)
Opinions of the Board of Supervisors on the “Special Instructions of the Board of Directors on the Issuance of Internal Control Audit Reports by Accounting Firms with Unqualified Opinions on Highlighted Matters”
Announcement of Resolutions of the 29th Meeting of the 11th Board of Directors of Hangzhou Tianmushan Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 22nd Meeting of the 11th Board of Supervisors of Hangzhou Tianmushan Pharmaceutical Co., Ltd.
Announcement of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on plans not to distribute profits in 2023
Announcement of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on the estimated amount of comprehensive financial credit and external guarantee for the company in 2024
Announcement of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on applying to withdraw the company's stock delisting risk warning and continuing to implement other risk warnings
Hangzhou Tianmushan Pharmaceutical Co., Ltd. 2023 Annual Report
2023 Audit Report
Special note by the board of directors on internal control audit reports issued by accounting firms with unqualified opinions on key points
Analysis
Price Target
No Data
